This paper is designed to give an overview of the mechanism of androgen action and some of the factors that can affect it. The discussion of androgen action includes androgen transport in the blood, metabolism, receptor binding, nuclear activation and selected aspects of biological response. The importance of recognizing interspecies and interstrain differences in specific aspects of androgen action is mentioned. Some examples of the effects of environmental agents on androgen metabolism, receptor binding and biological response are included.
Introduction
It has been recognized for some time that toxins can have far-reaching effects within the human body. Although it is only now coming under study, hormone action may be particularly susceptible to environmental factors due to the many steps involved in its manifestation. The testis is known to secrete several different hormones. The actions of two of them, inhibin and mullerian inhibiting factor, are not well defined and I will not discuss them further. The action of estrogen, which may be a major testicular product in some species, will be discussed in a later session.
The major focus of this paper will be on the mechanism of androgen action. Space does not permit me to go into the intricate details involved. These can be obtained from numerous reviews. Instead, I want to give an overview and to elucidate some general points that should be considered by toxicologists studying the mechanism of, or the effects of any compound on, androgen action.
It is necessary to consider a number of different aspects when evaluating a compound for its effect on androgen action. The biological efficacy of an androgen is influenced by its rate of synthesis or entry into the circulation, its metabolism in target and peripheral tissues, its availability for uptake by the target organs as well as its biochemical action within the target cell itself. 
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In my study of androgen action, I have used primarily the mouse kidney (1) (2) (3) (4) (5) . This organ offers several advantages. Although it is not androgendependent for its differentiation, it is androgenresponsive. Androgen receptors are present in both males and females. The kidney responds to androgens with cellular hypertrophy, but not hyperplasia, of Bowman's capsule and the proximal convoluted tubule. The absence of cell division means a constant population of cells is available for study. The activity of a number of specific enzymes including ,-glucuronidase, 3-galactosidase, d-amino acid oxidase, alcohol dehydrogenase, and arginase are increased by androgens. There are a number of genetic mutants, with altered androgen responsiveness, which provide powerful tools for disecting the regulation of androgen action (6) (7) (8) . We have made extensive use of the androgen-insensitive Tfm/Y mouse (3). The androgen insensitivity is a result of the effective absence of androgen receptors. Although male accessory sex tissues do not develop, several non-androgen-dependent tissues remain which are androgen-responsive in the normal animal. The Tfm/Y mouse has been extremely useful for determining those effects that are mediated via the androgen receptor.
Circulation
Some of the factors affecting testicular androgen biosynthesis were discussed by Ewing (9) . Once secreted into the blood, free androgens circulate in 11 equilibrium with androgens bound to plasma binding proteins. The plasma protein with the highest binding affinity for androgens is sex hormone binding globulin (TeBG or SHBG). This protein is present in some species such as man, nonhuman primates, rabbits, and sheep but not in others including rodents, dogs, cats, and birds (10) . In these latter species, testosterone is bound primarily to albumin. Some potent synthetic androgens, such as R1881, are not bound by TeBG which may, in part, account for their increased androgenicity. Any agents, such as estrogens or drugs that alter the synthesis and thus, the plasma concentration, of hormone binding proteins will ultimatelv affect the rates of testosterone biosynthesis and metabolism (11, 12) .
Metabolism
Androgens are metabolized in the liver, lung and other peripheral tissues as well as in the target organs themselves. In the liver and lung, this metabolism is primarily degradative. Changes in degradative enzymatic activities can alter the metabolic clearance rate and, thus, the effective biological activity of a hormone. While some hepatic steroid metabolizing enzymes function constitutively, the activity of others may be affected by hormones, drugs or toxins (13) (14) (15) . Some hepatic enzymes need a defined hormonal milieu during a critical neonatal period for normal activity to develop in the adult (15) . Species differences in the mode of regulation and activity of hepatic steroid metaboliiing enzymes may result in differences between species in the biological activity of androgens. We have reported marked species differences in the clearance rate and the effect on hepatic metabolism of several synthetic progestins known to affect androgen action (16) . These differences in hepatic metabolism are just one reason why data on biological activity gained in one species, or for that matter one strain, does not necessarily apply to another.
In target organs testosterone may be reduced to 5ao-dihydrotestosterone or aromatized to estrogens [Eq. (1) endogenous male hormone. This is in contrast to estrogen and progesterone target tissues, in which the active steroid is uniformly the major steroid secreted by the gonad. However, when we injected 3H-testosterone into mice we found only unmetabolized 3H-testosterone in renal nuclei ( Fig. 1) 
(5).
Subsequent work by ourselves and others have demonstrated that in androgen target tissues, the active steroid may be testosterone or DHT depending on the presence or absence of the enzyme 5a-reductase (18) . As data have accumulated it has become evident that not only are there differences in the active androgen between tissues of the same species but that there may also be differences between species when only a single tissue is compared. Generally, in the adult animal, 5oL-reductase is low to absent in kidney, muscle, submandibular gland and testis and present in skin, accessory sex tissues and portions of the brain and pituitary. In those tissues that lack 5a-reductase, exogenous administration of DHT will also induce nuclear uptake and androgenic responses in these tissues ( Fig. 1) , since the androgen receptor will bind either testosterone or DHT with high affinity. Since the biological responses to all steroids are initiated in the nucleus, it is important to determine the active intranuclear form of any compound that works via a steroid receptor. The compound injected or found in highest concentration in the blood is not necessarily what is concentrated in the nucleus.
An interesting example of the importance of target organ metabolism in determining the active steroid is given by the study of Wilson and colleagues on the sexual differentiation of the human and rabbit fetus (19, 20) . They showed that, although DHT is the active androgen in all male accessory sex tissues in the adult, in utero, testos- (1) uptake in rat prostate 'H-5u-dihydrotestosterone (DHT) was found after an injection of 3H-testosterone (17) . Thus, DHT was thought to be the active 12 TOTAL TESTO DHT DIOL FIGURE 1. 'H-androgens isolated from female mouse kidney nuclei following the IV administration of the TH-steroid indicated (5 April 1981 kidney, DHT was converted to the androstanediols at a rapid rate even at 4°C (Fig. 2) (1) .
The importance of aromatization of testosterone in the sexual differentiation and subsequent function of the brain was first suggested by Naftolin et al. in 1972 and since then has received a great deal of attention (22, 23 
Nuclear Response
The binding of androgen by the receptor is necessary for in vivo receptor "activation," such that now the receptor, complexed with the steroid, is translocated into the nucleus where it is bound at specific acceptor sites on chromatin (18, [24] [25] [26] 36) . This activation step apparently represents a change in size and conformation of the receptor with the loss or gain of an additional protein moiety. The intranuclear binding of the complex results in its concentration and nuclear retention for several hours.
While the steroid is necessary for the in vivo activation and subsequent nuclear entry of the receptor, it is the protein and its interaction with chromatin that initiates subsequent events. The androgen insensitivity of the Tfm/Y mouse is due to the absence of androgen receptors so that target tissue nuclei remain unstimulated even in the presence of androgen. Although the activated hormone-receptor complex can bind to DNA in a Environmental Health Perspectives nonspecific fashion, the chromosomal, non-histone proteins play an active role in regulating receptor interaction at specific, appropriate sites within the genome of target tissues. The processes involved in the interaction of the steroid receptor complex and the acceptor sites on chromatin are not well understood. Target organ chromatin does provide greater specificity of acceptor sites than does nontarget organ chromatin. However, the overall apparent heterogeneity in nuclear binding sites results in classes of acceptor sites which differ in their binding affinity. The biological importance of these different classes of acceptor sites is not known.
One of the earliest responses to androgen treatment that can be detected is an increase in the activity of nuclear RNA polymerase I (nucleolar) and II (nucleoplasmic) activity. We have shown that a single dose of testosterone results in a biphasic increase in RNA polymerase I and II activity in mouse kidney nuclei (Fig. 3) 
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Interestingly, the androgenic progestin, medroxyprogesterone acetate (MPA) and the antiandrogenic progestin, cyproterone acetate, also induced an increase in polymerase activity. The increase in polymerase activity in response to steroid treatment may be due to an activation or an increase in the number of polymerase molecules, to an increase in template capacity or to an increase in the rate of mRNA chain elongation. When testosterone and MPA were compared they were found to differ in their effects on chromatin template activity of specific polymerase molecules and chain elongation. It is probable that different hormones in different tissues exert different effects on each of these parameters. Another very early and probably very important intranuclear response to androgen treatment is the phosphorylation of nuclear non-histone proteins including the polymerases. Although it has been known for some time that androgen treatment results in an increase in mRNA synthesis in target organs, it has not been until recently that several specific mRNA's have been identified. These include mRNA for major urinary protein (MUP) in mouse liver (37) , ax2 globulin in rat liver (38) , aldolase (39) and prosta[tic binding protein (40) in rat prostate and 3-glucuronidase (41) and a protein of unknown function (42) in mouse kidney.
Concomitant with the increase in specific mRNA's, there is a general increase in rRNA. The overall result is increased synthesis on cytoplasmic polysomes of specific proteins which are characteristic for the individual target tissues involved. In some tissues a later response is the increase in DNA polymerase and cell division.
Biological Response
Even after the steroid receptor complex has finally induced a nuclear response there are specific factors which regulate the biological response of individual end points. We have been interested in studying some of the genetic factors regulating specific androgen effects in the mouse.
As mentioned earlier, a number of different proteins in mouse kidney respond specifically to androgen stimulation. In no instance was a response obtained in Tfm/Y mice. 1-Glucuronidase has been a most useful endpoint to study because of its known genetic regulation. Alleles for the structural as well as the regulatory gene have been identified (8) . The regulatory gene, Gur, is specific for 3-glucuronidase response to androgens in the kidney and represents the only gene known to regulate steroid response. Most mouse strains have been found to be high (Gura) or low (Gurb) responders. This response is regulated at the level of transcription since the degree of response is directly correlated with differences in mRNAi3glueur nidase and 3-glucuronidase synthesis. We have snown that Gur also regulates the response of glucuronidase to the androgenic progestin, medroxyprogesterone acetate (Fig. 4) (4) . This is further evidence that Gur is related to androgen receptor-chromatin interaction.
Another as yet incompletely described, regulation of glucuronidase response is hypophysectomy (8) FIGURE 4 . Effect of (-) testosterone and (--) medroxyprogesterone acetate on mouse kidney 3-glucuronidase activity in a strain with Gura/a (A/J) and Gurb7b (C57BL/6 J) type response. Steroid (1 and 3 mg, respectively) was administered daily (4).
sponse of glucuronidase synthesis and activity is greatly reduced. Even so, the difference between Gura and Gurb responses is maintained. Administration of growth hormone or prolactin will partially restore the response.
We have also done a few studies in the area of toxicology. CHC13 and dimethylnitrosamine (DMN) are extremely active in male kidney but not so in female kidney. Both the toxicity of CHC13 and the metabolism of DMN to a mutagen can be induced in females by treatment with testosterone or androgenic progestins (43) (44) (45) . These effects of androgens are mediated via the androgen receptor as suggested by the insensitivity of the Tfm/Y mouse and the inhibition by antiandrogens. In both instances, marked interstrain differences were noted. In neither case did the differences correlate with differences in glucuronidase responsiveness. The effects on liver were not affected by androgen treatment. Species and strain differences were also noted for liver when the hepatic response of ethylmorphine N-demethylase to testosterone and several synthetic C21 progestins was studied (46) . It is, thus, evident that androgens can have important effects on drug metabolism or the manifestation of toxic effects.
From the above examples it should be obvious that tissue and specific genetic factors may have major effects on the expression of the final biological response. In the study of the effects of any androgen or other compound capable of affecting androgen action it is important to study the response in several tissues and, if possible, in several strains or species. The latter is particularly important when animals as unique as inbred strains of mice are used. Animals with definitive mutations may offer useful probes for the further understanding of the biochemical action of androgens and the factors that affect it.
